LAST CHANCE ✨ Up To 25% Off Revolutionary Relief

Save on all Bonafide products before midnight.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌    OUR WORLD MENOPAUSE MONTH DEAL IS ENDING SOON OUR WORLD MENOPAUSE MONTH DEAL IS ENDING SOON

Don't miss out on revolutionary relief Don't miss out on revolutionary relief

It's the final hours of our World Menopause Month deal. Get the relief you deserve. Take advantage of this sale before it ends at midnight.

Two ways to save

10% off on non-subscription orders†. Use code WMMSAVE 25% off + free shipping on the first month of a subscription†. Use code WMM25

10% off on non-subscription orders†. Use code WMMSAVE 25% off + free shipping on the first month of a subscription†. Use code WMM25

Shop Now

Bonafide provides safe, scientifically validated relief from menopausal symptoms.*

83% of women experience reduced vaginal dryness1

Shop Revaree

84% of women experience overall symptom relief2

84% of women experience overall symptom relief2

Shop Relizen

95% of women experience relief from vaginal odor at 1 month of use3

Shop Clairvee

84%  of women experience increased physical arousal4

84%  of women experience increased physical arousal4

Shop Ristela

75%  of women experience relief from mood swings and irritability5

Shop Serenol

92% of women experience improved hair volume6

92% of women experience improved hair volume6

83% of women are more satisfied with the look of their skin6

83% of women are more satisfied with the look of their skin6

82% of women experience an increase in hair thickness7

82% of women experience an increase in hair thickness7

Shop Silvessa

Join the conversation

1. Dweck A, MS MD FACOG, Bernsley D, Sylla S, Komorowski J, MS CNS. A National Survey on Patient Satisfaction and Use Trends with Revaree, a Hyaluronic Acid Suppository, for Vaginal Dryness. The Journal of Sexual Medicine. 2022   2. Bernsley D, Sylla S, Komorowski J. Menopause. 2021;28(12):P-4.   3. Results from an open-label clinical study.   4. Kellogg Spadt, A. Dweck. The Effect of Ristela Supplementation on Female Sexual Function in Women Taking Antidepressants: An Open Label Trial. J Sex Med. 2020;17(7)3: S259-S260.   5. Winther K, et al. Curr Ther Res Clin Exp. 2002;63(5);344-353.   6. Sylla S, et al. Current Developments in Nutrition. 2021; 5:Supplement_2:37. 3 month open-label experience trial on the ingredients in Silvessa.   7. Sylla S, et al. Current Developments in Nutrition. 2021; 5:Supplement_2:37.   - ADVERTISEMENT - †Save 10% on your one-time purchase of a non-subscription product. Save 25% on your first month of any new monthly subscription plan. Savings based on our buy more, save more subscription pricing. Offer is redeemable towards first subscription purchase only. Expires 10/29/2023 at 11:59pm EST. © 2023 Bonafide Health, LLC. All Rights Reserved. 500 Mamaroneck Avenue, Suite 510, Harrison NY 10528   DRA5202102623 Help Center | Unsubscribe

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

"The Biggest Drug Ever" Is Coming

UBS bank predicts it will become "The Biggest Drug Ever." Unsubscribe A Message from Behind the Markets Dear Fellow Investor, UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. That's 4 times bigger than Lipitor, Zoloft and Metformin... COMBINED. It's set for FDA approval in the next 90 days. We believe an FDA approval could send shares soaring 678%. Get the name of the stock here >>> "The Buck Stops Here,"

This message is a paid advertisement sent on behalf of Behind the Markets, a third-party advertiser of MarketBeat. Why did I receive this email?   If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.   If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.   © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Buy THIS stock before Taiwan is attacked

Don't Miss This Digital Asset Summit!

Dear Investor, There's an incredible virtual event unfolding on October 26th, and I truly believe it's one you can't afford to miss! This gathering of digital currency experts is right around the corner (and FREE). One of the co-hosts who I know, has allowed me to pass along this free registration link to you, so be sure to give this a quick read and set a reminder to attend this online digital asset investing training event. And here's the best part: you can soak in all its wisdom from the comfort of your home, with zero travel involved! Why is this a must-attend? You'll discover how to: Dive into secrets on pinpointing early, promising digital projects. Arm yourself with tools to protect your digital assets from evolving threats. Master the knack of chart interpretation for optimized digital asset trading. Journey into the core of the digital universe, right from blockchain intricacies to the horizon of the metaverse. And so much more... With a line-up of over 27 visionaries in the field, this isn't just another event; it's the virtual gathering of the year. Claim Your Complimentary Virtual Ticket Here. I would love it if you took just 30 seconds to go here and grab your virtual event ticket while they're still free… Slots, especially the free ones, are going like hotcakes. Secure yours today. Reserve Your Virtual Seat Now Best wishes, Brett Fogle, Co-Founder Moonstream P.S. Revolutionize your digital asset journey with insights straight from the industry's top minds. Many invest a fortune for such knowledge. Here's your golden opportunity to access it, absolutely free. Advertising Disclosure: This email may contain paid advertisements. Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world. We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive. If you do not want to receive emails from us, you can follow this link to unsubscribe. or click the unsubscribe link at the bottom of the email that you do not want to receive. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. If you can't see this message, view it in your browser. You are receiving this e-mail at stevenmagallanes520.nims@blogger.com as a part of your free subscription to the Spotlight Newsletter. To read our privacy policy follow this link. or If you do not want to receive emails from us, you can follow this link to unsubscribe. To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311 Website: Summa Money Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2022 Summa Money. All rights reserved. If you do not want to receive emails from us, you can follow this link to unsubscribe. FROM THE SPOTLIGHT NEWSLETTER

In order to unsubscribe from this mailing list, please click here

Unlocking the Digital Currency Future - Are You In?

Dear Investor, Navigating the volatile waves of the digital currency market can be challenging, even for the seasoned enthusiast. Trends change in the blink of an eye, new projects emerge daily, and the sheer abundance of information can sometimes be overwhelming. Are you searching for some clarity amidst this digital chaos? Mark your calendar for October 26-28, 2023, because an unprecedented gathering of digital currency experts is coming your way. I'm excited to share an exclusive invitation to an event like no other — tailored to equip you with insights, strategies, and the confidence to traverse the next decade in digital assets. Go here to learn the full details Expect actionable insights, deep dives into key topics like DEFI, wallet security, and the future of blockchain. Most importantly, seize this opportunity to connect with like-minded digital asset enthusiasts from all over the world. I believe this gathering could be a game-changer for many. Will you be joining us? Warm Regards, Brett Fogle, Co-Founder Moonstream P.S. This event has been curated especially for digital asset enthusiasts and investors. Whether you're just starting out or you're deep in the game, there's something for everyone. Go here to learn the full details Advertising Disclosure: This email may contain paid advertisements. Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world. We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive. If you do not want to receive emails from us, you can follow this link to unsubscribe. or click the unsubscribe link at the bottom of the email that you do not want to receive. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. If you can't see this message, view it in your browser. You are receiving this e-mail at stevenmagallanes520.nims@blogger.com as a part of your free subscription to the Spotlight Newsletter. To read our privacy policy follow this link. or If you do not want to receive emails from us, you can follow this link to unsubscribe. To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311 Website: Summa Money Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2022 Summa Money. All rights reserved. If you do not want to receive emails from us, you can follow this link to unsubscribe. FROM THE SPOTLIGHT NEWSLETTER

In order to unsubscribe from this mailing list, please click here